Experts Say Drug Transparency Bill Has Been Stripped of Critical Provisions

Landmark legislation designed to alert consumers to where their drugs were made is headed for a full Senate vote, but safety experts say the transparency bill has been stripped of two of its most critical provisions. The Clear Labels Act was introduced earlier this year by Sens. Rick Scott, R-Fla., and Kirsten Gillibrand, D-N.Y., after lawmakers and drug safety experts called for more…
Source

Original

The FDA’s Lax Generic Drug Rules Can Put Patients’ Lives at Risk

Wrapped in a flashy fur coat she’d found at a thrift store for the occasion, Hannah Goetz blew out the candles on her favorite red velvet cheesecake. It was her 21st birthday. The celebration with her family that evening in February 2023 was a milestone not just for her age, but because she was alive. Three and a half years before, her lungs had collapsed from cystic fibrosis.
Source

Original